Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (58)

2023

  1. ASO Visual Abstract: Accuracy and Survival Outcomes After National Implementation of Sentinel Lymph Node Biopsy in Early-Stage Endometrial Cancer

    Annals of surgical oncology, Vol. 30, Núm. 12, pp. 7669-7670

  2. Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer

    Annals of Surgical Oncology, Vol. 30, Núm. 12, pp. 7653-7662

  3. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, Vol. 183, pp. 109589

  4. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer

    International Journal of Gynecological Cancer, Vol. 33, Núm. 6, pp. 862-875

  5. Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  6. Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis

    Annals of Surgical Oncology, Vol. 30, Núm. 12, pp. 7645-7652

  7. Oncological outcomes among young women with non-epithelial ovarian cancer: The YOC-Care study (Young Ovarian Cancer - Care)

    International Journal of Gynecological Cancer, Vol. 33, Núm. 6, pp. 915-921

  8. Prognostic factors in patients with uterine sarcoma: The SARCUT study

    International Journal of Gynecological Cancer, Vol. 33, Núm. 6, pp. 897-904

  9. Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: Results from an international multi-institutional study

    International Journal of Gynecological Cancer

  10. Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme

    European Journal of Cancer, Vol. 182, pp. 3-14

  11. The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer—A GEICO Study

    Cancers, Vol. 15, Núm. 11